The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 μg and ethinylestradiol 15 μg

被引：0

作者：

Bocci, A. ^{[1
]}

Spielniann, D. ^{[1
]}

Azzini, Pr ^{[1
]}

Guaschino, Pr ^{[1
]}

Affronti, G. ^{[1
]}

Villani, Pr ^{[1
]}

Boselli, Pr ^{[1
]}

Genazzani, Pr ^{[1
]}

Flamigni, Z. C. ^{[1
]}

Omodei, U. ^{[1
]}

Bolis, P. ^{[1
]}

Marsoni, V. ^{[1
]}

Luerti, M. ^{[1
]}

Simenel, J. L. ^{[1
]}

Ouvry-Neveu, B. ^{[1
]}

Andre, G. ^{[1
]}

David, S. ^{[1
]}

Durand, J. L. ^{[1
]}

Ehret-Mentre, C. ^{[1
]}

Gensburger, J. M. ^{[1
]}

Goetzmann, P. ^{[1
]}

Jung-Faerber, S. ^{[1
]}

Keller, D. ^{[1
]}

Lempereur, M. ^{[1
]}

Plumere, C. ^{[1
]}

Spielmann, A. ^{[1
]}

Katz, J. L. ^{[1
]}

Sebaoun, J. ^{[1
]}

Belaisch, J. ^{[1
]}

Hammer, F. ^{[1
]}

Salama, B. ^{[1
]}

Aissaoui, S. ^{[1
]}

Taube, A. M. ^{[1
]}

Nakache, H. ^{[1
]}

Soria, J. ^{[1
]}

Joffo, M. ^{[1
]}

Lardenois, H. ^{[1
]}

Leclerc, P. ^{[1
]}

Ponsar, C. ^{[1
]}

Saubry-Bobet, V. ^{[1
]}

Blaiset, E. ^{[1
]}

Veyres, F. ^{[1
]}

Clamp, M. ^{[1
]}

Menon, K. V. K. ^{[1
]}

Moran, D. G. ^{[1
]}

Randall, S. ^{[1
]}

Shaw, P. J. ^{[1
]}

Bruni, V. ^{[1
]}

Massobrio, M. ^{[1
]}

Crosignani, P. ^{[1
]}

机构：

[1] Wyeth Ayersr Res, F-92031 Paris, France

来源：

EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE | 1999年 / 4卷

关键词：

Oral contraceptive; Contraceptive efficacy; Gestodene; Ethinylestradiol;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Objective The safety and contraceptive efficacy of a new 24-day regimen of an oral contraceptive combination containing gestodene (GTD) 60 mu g and ethinylestradiol (EE) 15 mu g was evaluated in an open-label, multicenter study. Methods Adult women received GTD 60 mu g/EE 15 mu g from day 1 to 24 and 4 days of placebo during a 28-day cycle for either 13 or 19 cycles. Results Of the 1515 subjects enrolled, 1496 were included in the intent-to-treat analysis. A total of three pregnancies were reported during the 18 194 treatment cycles of the study, yielding a Pearl index of 0.21. Life-table analysis, based on 16 954 cycles, gave an accidental pregnancy rate of 0.0033. The most frequent adverse events were headache (reported in 35% of subjects), absence of bleeding (16%), flu-like syndrome (15%), pharyngitis (15%) and abdominal pain (15%). The most frequent reasons for withdrawal from the study were metrorrhagia, flu syndrome and absence of bleeding. Analyses of withdrawal and intermenstrual bleeding and spotting indicated acceptable cycle control. Conclusions The 24-day GTD 60 mu g/EE 15 mu g, regimen appears to be a well-tolerated and effective method for low-dose oral contraception. The current formulation offers an ultra-low steroidal dosage combined with a reduced pill-free interval to improve contraceptive efficacy.

引用

页码：9 / 15

页数：7

共 50 条

[31] A randomized trial to evaluate the efficacy and safety of a low-dose extended-regimen oral contraceptive
Kaunitz, Andrew M.
Anderson, Freedolph D.
Portman, David
OBSTETRICS AND GYNECOLOGY, 2006, 107 (04): : 86S - 86S
[32] Blood pressure stability in a normotensive population during intake of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 g gestodene
Endrikat, J
Gerlinger, C
Cronin, M
Ruebig, A
Schmidt, W
Düsterberg, B
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2001, 6 (03): : 159 - 166
[33] Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol
Anderson, FD
Gibbons, W
Portman, D
CONTRACEPTION, 2006, 73 (03) : 229 - 234
[34] Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen
Mansour, Diana
Verhoeven, Carole
Sommer, Werner
Weisberg, Edith
Taneepanichskul, Surasak
Melis, Gian Benedetto
Sundstrom-Poromaa, Inger
Korver, Tjeerd
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2011, 16 (06): : 430 - 443
[35] EFFECT OF A LOW-DOSE ORAL-CONTRACEPTIVE (150-MU-G LEVONORGESTREL AND 30-MU-G ETHINYLESTRADIOL) ON LACTATION
CAMPODONICO, I
GUERRERO, B
LANDA, LI
CLINICAL THERAPEUTICS, 1978, 1 (06) : 454 - 459
[36] Efficacy of the low-dose combined oral contraceptive chlormadinone acetate/ethinylestradiol: physical and emotional benefits
Heskamp, Marie-Luise S.
Schramm, Georg A. K.
CONTRACEPTION, 2010, 81 (01) : 49 - 56
[37] CLINICAL-EXPERIENCE WITH A MODERN LOW-DOSE GESTODENE-CONTAINING ORAL-CONTRACEPTIVE IN ADOLESCENTS
BRILL, K
SCHNITKER, J
ALBRING, M
ADVANCES IN CONTRACEPTION, 1994, 10 (04) : 237 - 247
[38] Bleeding profile of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg compared to a 21-day regimen.
Ellman, H
Archer, DF
FERTILITY AND STERILITY, 2005, 84 : S171 - S171
[39] A three year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene
Dusterberg, B
Ellman, H
Muller, U
Rowe, E
Muhe, B
GYNECOLOGICAL ENDOCRINOLOGY, 1996, 10 (01) : 33 - 39
[40] A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 mu g ethinylestradiol 75 mu g gestodene and 30 mu g ethinylestradiol 75 mu g gestodene, with respect to efficacy, cycle control, and tolerance
Endrikat, J
Muller, U
Dusterberg, B
CONTRACEPTION, 1997, 55 (03) : 131 - 137

← 1 2 3 4 5 →